Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VML-0501 vaginal danazol versus oral Danatrol pharmacokinetic study in endometriosis
2017-000988-32Phase 2Terminated
- Sponsor
- Viramal
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of danazol in endometriosis (2 arms), sponsored by Viramal. Primary endpoints: Serum danazol concentration and Peritoneal fluid danazol concentration. Started Nov 2020; status: terminated.
02
Drugs
danazol
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2017-000988-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000988-32.